SMT201600126B - Solfonammidi per la prevenzione del diabete - Google Patents

Solfonammidi per la prevenzione del diabete

Info

Publication number
SMT201600126B
SMT201600126B SM201600126T SM201600126T SMT201600126B SM T201600126 B SMT201600126 B SM T201600126B SM 201600126 T SM201600126 T SM 201600126T SM 201600126 T SM201600126 T SM 201600126T SM T201600126 B SMT201600126 B SM T201600126B
Authority
SM
San Marino
Prior art keywords
sulphonamids
diabetes
prevention
Prior art date
Application number
SM201600126T
Other languages
English (en)
Italian (it)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompé Farmaceutici S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompé Farmaceutici S P A filed Critical Dompé Farmaceutici S P A
Publication of SMT201600126B publication Critical patent/SMT201600126B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SM201600126T 2009-10-06 2016-05-03 Solfonammidi per la prevenzione del diabete SMT201600126B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
PCT/EP2010/064920 WO2011042465A1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes
EP10768898.8A EP2485724B1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
SMT201600126B true SMT201600126B (it) 2016-07-01

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600126T SMT201600126B (it) 2009-10-06 2016-05-03 Solfonammidi per la prevenzione del diabete

Country Status (24)

Country Link
US (2) US8846755B2 (enExample)
EP (2) EP2308485A1 (enExample)
JP (1) JP5745526B2 (enExample)
KR (1) KR101737656B1 (enExample)
CN (1) CN102639128B (enExample)
AU (1) AU2010305384B2 (enExample)
BR (1) BR112012007989B1 (enExample)
CA (1) CA2776021C (enExample)
CY (1) CY1117599T1 (enExample)
DK (1) DK2485724T3 (enExample)
EA (1) EA021788B1 (enExample)
ES (1) ES2570463T3 (enExample)
HR (1) HRP20160399T1 (enExample)
HU (1) HUE028132T2 (enExample)
IL (1) IL219038A (enExample)
ME (1) ME02385B (enExample)
MX (1) MX2012004087A (enExample)
NZ (1) NZ599171A (enExample)
PL (1) PL2485724T3 (enExample)
RS (1) RS54693B1 (enExample)
SI (1) SI2485724T1 (enExample)
SM (1) SMT201600126B (enExample)
WO (1) WO2011042465A1 (enExample)
ZA (1) ZA201202462B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
CN117503933A (zh) * 2016-10-03 2024-02-06 儿童医疗中心公司 糖尿病肾病的预防和治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
CN1934077B (zh) 2004-03-23 2010-09-29 冬姆佩制药股份公司 2-苯基丙酸衍生物及含有它们的药物组合物
DE602004003673T2 (de) 2004-03-25 2007-10-04 Dompe' Pha.R.Ma S.P.A. Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen
KR20110014141A (ko) * 2008-03-20 2011-02-10 카롤러스 테라퓨틱스, 인코포레이티드 염증을 치료하는 방법
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes

Also Published As

Publication number Publication date
EP2485724A1 (en) 2012-08-15
SI2485724T1 (sl) 2018-12-31
NZ599171A (en) 2014-03-28
AU2010305384A1 (en) 2012-04-26
US20130059908A1 (en) 2013-03-07
DK2485724T3 (en) 2016-05-02
HK1174557A1 (en) 2013-06-14
US8846755B2 (en) 2014-09-30
HUE028132T2 (en) 2016-11-28
JP5745526B2 (ja) 2015-07-08
PL2485724T3 (pl) 2016-07-29
HRP20160399T1 (hr) 2016-05-20
IL219038A0 (en) 2012-06-28
BR112012007989B1 (pt) 2019-10-22
CN102639128B (zh) 2014-02-26
WO2011042465A1 (en) 2011-04-14
EA021788B1 (ru) 2015-08-31
EP2308485A1 (en) 2011-04-13
CA2776021A1 (en) 2011-04-14
KR20120083889A (ko) 2012-07-26
KR101737656B1 (ko) 2017-05-18
US9556115B2 (en) 2017-01-31
CN102639128A (zh) 2012-08-15
ME02385B (me) 2016-09-20
EA201270512A1 (ru) 2012-11-30
EP2485724B1 (en) 2016-02-10
MX2012004087A (es) 2012-08-23
US20150011639A1 (en) 2015-01-08
IL219038A (en) 2015-07-30
RS54693B1 (sr) 2016-08-31
CY1117599T1 (el) 2017-04-26
CA2776021C (en) 2017-08-01
ES2570463T3 (es) 2016-05-18
JP2013506703A (ja) 2013-02-28
ZA201202462B (en) 2013-06-26
AU2010305384B2 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
NL301211I1 (nl) Olipudase alfa
SMT201600216B (it) Ottaidropirrolo[3,4.c]pirroli disostituiti come modulatori del recettore di orexina
BRPI1016032A2 (pt) conjunto dual de tensionador.
DK2502172T3 (da) Hypoglykæmiske behandlingssystemer
EP3865162C0 (en) RINSE SYRINGE ASSEMBLY
BRPI1005525A2 (pt) compostos de azaazuleno
IT1402748B1 (it) Procedimento per la raffinazione del greggio
HUE045367T2 (hu) Kombinált terápia diabétesz kezelésére
SMT201600412B (it) Metodi per il trattamento del diabete con antagonisti del dll4
BRPI1016190A2 (pt) compostos farmacêuticos.
EP2479575A4 (en) BLOOD GLUCOSE METER
DE112010000740A5 (de) Endoskop
BRPI1012155A2 (pt) cateter de segurança.
FI20090267A0 (fi) Jauhin
IT1393136B1 (it) Procedimento per la preparazione del bosentan
EP2436239A4 (en) LED DRIVER
EP2410957A4 (en) SUPPORT BANDAGE OF THE PLANTAIRE VISOR
BRPI1011535A2 (pt) tratamento de distúrbios resistentes à insulina.
EP2440937A4 (en) A diagnostic method
EP2388861A4 (en) CONNECTOR
FR2947857B1 (fr) Agencement de deshuileur
SMT201600126B (it) Solfonammidi per la prevenzione del diabete
BR112012006693A2 (pt) combinação
EP2485746A4 (en) CELL PROTECTIVE OR THERAPEUTIC PLANT COMPOSITION
FI20096192A0 (fi) Kohteen valaiseminen